FDA NDC Directory · JSON-LD · Markdown

CHOLESTYRAMINE

NDC 70771-1070 · HUMAN PRESCRIPTION DRUG · POWDER, FOR SUSPENSION

Labeler / ManufacturerZydus Lifesciences Limited
Marketing categoryAbbreviated NDA (generic) · App ANDA202902
Dosage form / routePOWDER, FOR SUSPENSION · ORAL
Active ingredientsCHOLESTYRAMINE (4 g/5.5g)
Marketing started20170608
Package count2

External sources

Source: openFDA. Public-domain (CC0).